These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3908282)

  • 1. Timolol-related reduction in mortality and reinfarction in diabetic patients surviving acute myocardial infarction.
    Gundersen T; Kjekshus J
    Horm Metab Res Suppl; 1985; 15():58-60. PubMed ID: 3908282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Timolol reduces mortality and reinfarct in patients surviving an acute myocardial infarct. The Norwegian Multicenter Study Group].
    MMW Munch Med Wochenschr; 1981 May; 123(22):929-38. PubMed ID: 6787417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary prevention of myocardial infarction in the elderly.
    Abrahamsen AM; Gundersen T; Rønnevik P
    Curr Med Res Opin; 1982; 7(Suppl 1):68-78. PubMed ID: 7105797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Norwegian Multicenter Study of Timolol after Myocardial Infarction.
    Pedersen TR
    Circulation; 1983 Jun; 67(6 Pt 2):I49-53. PubMed ID: 6342838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicenter study on timolol in secondary prevention after myocardial infarction.
    Acta Med Scand Suppl; 1983; 674():1-129. PubMed ID: 6580807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Timolol treatment after myocardial infarction in diabetic patients.
    Gundersen T; Kjekshus J
    Diabetes Care; 1983; 6(3):285-90. PubMed ID: 6347581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Timolol Myocardial Infarction Study: an evaluation of selected variables.
    Rodda BE
    Circulation; 1983 Jun; 67(6 Pt 2):I101-6. PubMed ID: 6342836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term mortality in patients with myocardial infarction: impact of early treatment with captopril for 4 weeks.
    Liu L;
    Chin Med J (Engl); 2001 Feb; 114(2):115-8. PubMed ID: 11780187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Six-year follow-up of the Norwegian Multicenter Study on Timolol after Acute Myocardial Infarction.
    Pedersen TR
    N Engl J Med; 1985 Oct; 313(17):1055-8. PubMed ID: 2864634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Timolol-related reduction in mortality and reinfarction in patients ages 65-75 years surviving acute myocardial infarction. Prepared for the Norwegian Multicentre Study Group.
    Gundersen T; Abrahamsen AM; Kjekshus J; Rønnevik PK
    Circulation; 1982 Dec; 66(6):1179-84. PubMed ID: 6128084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Beta-blockade with timolol after myocardial infarction (author's transl)].
    Meister W
    MMW Munch Med Wochenschr; 1981 Sep; 123(38):1403-6. PubMed ID: 6793858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The importance of pre- and postinfarction angina on timolol-related reduction in mortality and reinfarction.
    Gundersen T; Kjekshus J
    Clin Cardiol; 1985 Feb; 8(2):87-92. PubMed ID: 3882290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of an antidiabetic treatment with sulfonylurea drugs on long-term survival after acute myocardial infarction in patients with type 2 diabetes. The LAngendreer Myocardial infarction and Blood glucose in Diabetic patients Assessment (LAMBDA).
    Meier JJ; Deifuss S; Klamann A; Schmiegel W; Nauck MA;
    Exp Clin Endocrinol Diabetes; 2003 Sep; 111(6):344-50. PubMed ID: 14520601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic role of the glucometabolic status assessed in a metabolically stable phase after a first acute myocardial infarction: the SHEEP study.
    Janszky I; Hallqvist J; Ljung R; Ahlbom A; Hammar N
    J Intern Med; 2009 Apr; 265(4):465-75. PubMed ID: 19019187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary prevention after myocardial infarction: subgroup analysis of patients at risk in the Norwegian Timolol Multicenter Study.
    Gundersen T
    Clin Cardiol; 1985 May; 8(5):253-65. PubMed ID: 3888463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small differences in non-fatal in-hospital reinfarctions complicating acute myocardial infarction as observed in current randomised controlled trials will not essentially influence long-term mortality. Results from the Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) Registry.
    Zahn R; Schiele R; Schneider S; Dönges K; Senges J
    Z Kardiol; 2003 Oct; 92(10):847-51. PubMed ID: 14579049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus.
    Stranders I; Diamant M; van Gelder RE; Spruijt HJ; Twisk JW; Heine RJ; Visser FC
    Arch Intern Med; 2004 May; 164(9):982-8. PubMed ID: 15136307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fasting glucose in acute myocardial infarction: incremental value for long-term mortality and relationship with left ventricular systolic function.
    Aronson D; Hammerman H; Kapeliovich MR; Suleiman A; Agmon Y; Beyar R; Markiewicz W; Suleiman M
    Diabetes Care; 2007 Apr; 30(4):960-6. PubMed ID: 17392556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction.
    Norwegian Multicenter Study Group
    N Engl J Med; 1981 Apr; 304(14):801-7. PubMed ID: 7010157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of timolol on mortality and reinfarction after acute myocardial infarction: prognostic importance of heart rate at rest.
    Gundersen T; Grøttum P; Pedersen T; Kjekshus JK
    Am J Cardiol; 1986 Jul; 58(1):20-4. PubMed ID: 3524181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.